Loading...
Atai Life Sciences N.V.
ATAI•NASDAQ
Healthcare
Biotechnology
$3.57
$-0.17(-4.55%)
Atai Life Sciences N.V. (ATAI) Financial Performance & Income Statement Overview
Review Atai Life Sciences N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.91%
↓ 1.91%
Operating Income Growth
18.16%
↑ 18.16%
Net Income Growth
-271.09%
↓ 271.09%
Operating Cash Flow Growth
2.00%
↑ 2.00%
Operating Margin
-5312.18%
↓ 5312.18%
Gross Margin
87.92%
↑ 87.92%
Net Profit Margin
-7997.16%
↓ 7997.16%
ROE
-102.40%
↓ 102.40%
ROIC
-59.16%
↓ 59.16%
Atai Life Sciences N.V. (ATAI) Income Statement & Financial Overview
Review Atai Life Sciences N.V.'s (ATAI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$5000.00 | $40000.00 | $273000.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $82000.00 | $83000.00 |
| Gross Profit | -$5000.00 | $40000.00 | $191000.00 | -$83000.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $0.70 | |
| R&D Expenses | $18.94M | $12.38M | $12.61M | $11.45M |
| SG&A Expenses | $11.32M | $10.27M | $13.40M | $12.46M |
| Operating Expenses | $30.26M | $22.64M | $26.002M | $23.90M |
| Total Costs & Expenses | $30.26M | $22.64M | $26.002M | $23.98M |
| Interest Income | $193000.00 | $160000.00 | $118000.00 | $307000.00 |
| Interest Expense | $952000.00 | $783000.00 | $702000.00 | $687000.00 |
| Depreciation & Amortization | $225000.00 | $83000.00 | $82000.00 | $83000.00 |
| EBITDA | -$38.007M | -$25.60M | -$56.67M | -$24.91M |
| EBITDA Ratio | $7601.40 | -$639.92 | -$207.60 | |
| Operating Income | -$30.27M | -$22.60M | -$25.73M | -$23.98M |
| Operating Income Ratio | $6053.00 | -$565.05 | -$94.25 | |
| Other Income/Expenses (Net) | -$8.92M | -$3.86M | -$31.62M | -$1.60M |
| Income Before Tax | -$39.18M | -$26.46M | -$57.35M | -$25.68M |
| Income Before Tax Ratio | $7836.80 | -$661.58 | -$210.07 | |
| Income Tax Expense | -$193000.00 | -$178000.00 | $19000.00 | -$4000.00 |
| Net Income | -$38.96M | -$26.29M | -$57.31M | -$26.71M |
| Net Income Ratio | $7791.60 | -$657.15 | -$209.93 | |
| EPS | -$0.24 | -$0.16 | -$0.36 | -$0.17 |
| Diluted EPS | -$0.24 | -$0.16 | -$0.36 | -$0.17 |
| Weighted Avg Shares Outstanding | $160.16M | $160.62M | $160.39M | $158.89M |
| Weighted Avg Shares Outstanding (Diluted) | $160.16M | $160.62M | $160.39M | $158.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan